Department of Radiology
Found 13 results
Filters: Author is Fortea, Juan  [Clear All Filters]
2024
Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Bubu OM et al..  2024.  The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.. Res Sq.
2022
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al..  2022.  Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.
2020
Kamer AR, Craig RG, Niederman R, Fortea J, de Leon MJ.  2020.  Periodontal disease as a possible cause for Alzheimer's disease.. Periodontol 2000. 83(1):242-271.
2018
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS et al..  2018.  Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.. JAMA Psychiatry. 75(1):84-95.
Illán-Gala I, Pegueroles J, Montal V, Vilaplana E, Carmona-Iragui M, Alcolea D, Dickerson BC, Sánchez-Valle R, de Leon MJ, Blesa R et al..  2018.  Challenges associated with biomarker-based classification systems for Alzheimer's disease.. Alzheimers Dement (Amst). 10:346-357.
de Leon MJ, Pirraglia E, Osorio RS, Glodzik L, Saint-Louis L, Kim H-J, Fortea J, Fossati S, Laska E, Siegel C et al..  2018.  The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.. PLoS One. 13(2):e0191240.
Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, Alcolea D, Pegueroles J, Muñoz L, Belbin O et al..  2018.  Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.. Lancet Neurol. 17(10):860-869.
Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleó A, Molinuevo JLuis, Jagust WJ et al..  2018.  Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.. Alzheimers Dement. 14(7):913-924.
2017
de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E et al..  2017.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.. J Nucl Med. 58(9):1471-1476.
2016
Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al..  2016.  Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.
Varga AW, Wohlleber ME, Giménez S, Romero S, Alonso JF, Ducca EL, Kam K, Lewis C, Tanzi EB, Tweardy S et al..  2016.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.. Sleep. 39(11):2041-2048.
2015
Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, Carmona-Iragui M, Sala I, Sánchez-Saudinos M-B, Antón-Aguirre S et al..  2015.  APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.. Oncotarget. 6(29):26663-74.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJelle, Aalten P, Aarsland D, Alcolea D et al..  2015.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.. JAMA. 313(19):1924-38.